Practical Pharmacology for Alzheimer’s Disease

  • Takashi Kudo
  • Kenneth L. Davis
  • Rafael Blesa Gonzalez
  • David George Wilkinson

Table of contents

  1. Front Matter
    Pages i-viii
  2. Takashi Kudo
    Pages 27-33
  3. Rafael Blesa Gonzalez, Ignacio Flores, Roser Ribosa-Nogué
    Pages 63-103
  4. David G. Wilkinson
    Pages 105-117
  5. Back Matter
    Pages 137-141

About this book

Introduction

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

Keywords

Alzheimer Alzheimer's Disease Donepezil Galantamine Rivastigmine Symptomatic Drugs

Authors and affiliations

  • Takashi Kudo
    • 1
  • Kenneth L. Davis
    • 2
  • Rafael Blesa Gonzalez
    • 3
  • David George Wilkinson
    • 4
  1. 1.ToyonakaJapan
  2. 2.New YorkUSA
  3. 3.BarcelonaSpain
  4. 4.SouthhamptonUnited Kingdom

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-26206-2
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-26204-8
  • Online ISBN 978-3-319-26206-2
  • About this book
Industry Sectors
Biotechnology
Pharma